MIRA Pharmaceuticals Future Growth
Future criteria checks 0/6
MIRA Pharmaceuticals is forecast to grow revenue at 55.9% per annum. EPS is expected to grow by 32.8% per annum.
Key information
n/a
Earnings growth rate
32.8%
EPS growth rate
Pharmaceuticals earnings growth | 27.3% |
Revenue growth rate | 55.9% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 11 Jun 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 552 | N/A | 398 | N/A | 1 |
12/31/2025 | N/A | -9 | -10 | N/A | 2 |
12/31/2024 | N/A | N/A | 0 | N/A | 2 |
3/31/2024 | N/A | -12 | -5 | -5 | N/A |
12/31/2023 | N/A | -12 | -5 | -5 | N/A |
9/30/2023 | N/A | -8 | -4 | -4 | N/A |
6/30/2023 | N/A | -6 | -4 | -4 | N/A |
3/31/2023 | N/A | -7 | -5 | -5 | N/A |
12/31/2022 | N/A | -7 | -6 | -6 | N/A |
3/31/2022 | N/A | -4 | -3 | -3 | N/A |
12/31/2021 | N/A | -2 | -1 | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if MIRA's forecast earnings growth is above the savings rate (2.4%).
Earnings vs Market: Insufficient data to determine if MIRA's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if MIRA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MIRA is forecast to have no revenue next year.
High Growth Revenue: MIRA is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MIRA's Return on Equity is forecast to be high in 3 years time